US6551872012 - Common Stock
ACLARION INC
NASDAQ:ACON (4/18/2024, 7:00:00 PM)
Premarket: 0.3003 +0 (+1.15%)0.2969
0 (0%)
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Broomfield, Colorado and currently employs 7 full-time employees. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and, and a biomarker to optimize clinical treatments. The Company’s signal processing software and expert system transform raw spectral MRS data into clear metabolic biomarkers to help physicians determine between painful and nonpainful discs of the lumbar spine. The firm is using augmented intelligence in a post-processing algorithm to analyze and quantifies the biomarker data, generating ratio metrics for each lumbar disc that are individualized to a normative data set. The Company’s technology is focused on the care of patients suffering from chronic low back pain.
ACLARION INC
8181 Arista Place, Ste 100
Broomfield COLORADO
P: 18332752266
Employees: 7
Website: https://aclarion.com/
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday!
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Pre-market stock movers are the perfect way to start the week as we dive into the biggest stories moving shares on Monday!
Confirms predictive value of Nociscan for identifying painful discs.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Here you can normally see the latest stock twits on ACON, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: